Liability Risks in Clinical Research
Johnson, Lee J., Medical Economics
Answers to your questions
Q: I've been asked to serve as a clinical investigator for a new antibiotic for upper respiratory infections. The pharmaceutical company will pay me a fee for each patient enrolled and clinical trial completed in this study. What are the key liability issues? What happens if the antibiotic is found to have some serious adverse effects?
A: Informed consent is the key liability concern for physicians. Did the patient agree to participate in the study with full knowledge of the possibility of side effects or adverse reactions? The patient must be told that he is involved in experimental research, the risks and benefits of participating in the …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: Liability Risks in Clinical Research.
Contributors: Johnson, Lee J. - Author.
Magazine title: Medical Economics.
Volume: 79.
Issue: 3
Publication date: February 8, 2002.
Page number: 110.
© Advanstar Communications, Inc. Jan 23, 2009.
Provided by ProQuest LLC. All Rights Reserved.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset